Assessment of Somatic Symptom in Chinese Community-Dwelling People
NCT ID: NCT04815863
Last Updated: 2025-10-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
9110 participants
OBSERVATIONAL
2019-03-01
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-inferiority of Virtual vs. Traditional Methods in Adolescent Mental Health Literacy
NCT07238842
App-Based Self-Management for Somatic Symptom Disorder and MUS: A Pilot Study
NCT07296406
Research of Prevention and Intervention of Mental Health Problems
NCT01422447
Growth Mindset Intervention for Older Adults With Chronic Disease
NCT06550817
Multimodal Psychotherapy Training for Chinese Medical Students
NCT06258460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Investigators use Somatic Symptom Scale-China (SSS-CN) questionnaire to assess the presence and severity of the symptoms. Patient Heath Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder Screener (GAD-7) are used to evaluate depression and anxiety disorder respectively. The study aims to clarify the prevalence of somatic symptom, depression and anxiety disorders in China, to compare physical and psychological difference between the elderly and non-elderly and to explore risk factors for somatic symptom in the elderly.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Elderly
Over 60 years old
Assessment of somatic symptom disorder with SSS-CN
SSS-CN questionnaire is used to assess the presence and severity of the somatic symptoms
Assessment of depressive symptoms disorder with PHQ-9
PHQ-9 questionnaire is used to assess the presence and severity of the depressive symptoms
Assessment of anxiety disorder with GAD-7
GAD-7 questionnaire is used to assess the presence and severity of the anxiety disorder
Non-Elderly
Under 60 years old
Assessment of somatic symptom disorder with SSS-CN
SSS-CN questionnaire is used to assess the presence and severity of the somatic symptoms
Assessment of depressive symptoms disorder with PHQ-9
PHQ-9 questionnaire is used to assess the presence and severity of the depressive symptoms
Assessment of anxiety disorder with GAD-7
GAD-7 questionnaire is used to assess the presence and severity of the anxiety disorder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment of somatic symptom disorder with SSS-CN
SSS-CN questionnaire is used to assess the presence and severity of the somatic symptoms
Assessment of depressive symptoms disorder with PHQ-9
PHQ-9 questionnaire is used to assess the presence and severity of the depressive symptoms
Assessment of anxiety disorder with GAD-7
GAD-7 questionnaire is used to assess the presence and severity of the anxiety disorder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. undertook SSS-CN questionnaire, PHQ-9 and GAD questionnaires；
Exclusion Criteria
2. patient with cancer and central nervous system disease;
3. patients who have been previously confirmed serious mental disorders, mental retardation or dementia.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RenJi Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meng Jiang, MD
Role: STUDY_CHAIR
RenJi Hospital, School of Medicine, Shanghai Jiantong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Renji Hospital
Shanghai, Shanghai Municipality, China
Renji Hospital
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SSSCN202011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.